HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy
Abstract Cancer immunotherapies based mainly on the blockade of immune-checkpoint (IC) molecules by anti-IC antibodies offer new alternatives for treatment in oncological diseases. However, a considerable proportion of patients remain unresponsive to them. Hence, the development of novel clinical im...
Enregistré dans:
Auteurs principaux: | María Belén Palma, Diana Tronik-Le Roux, Guadalupe Amín, Sheila Castañeda, Alan M. Möbbs, María Agustina Scarafia, Alejandro La Greca, Marina Daouya, Isabelle Poras, Ana María Inda, Lucía N. Moro, Edgardo D. Carosella, Marcela N. García, Santiago G. Miriuka |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/894a26ff5d8c49e7b84811e2e58054c0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
celldeath: A tool for detection of cell death in transmitted light microscopy images by deep learning-based visual recognition.
par: Alejandro Damián La Greca, et autres
Publié: (2021) -
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
par: K. G. Paulson, et autres
Publié: (2018) -
HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
par: Geok Wee Tan, et autres
Publié: (2021) -
Downregulation of E-cadherin in pluripotent stem cells triggers partial EMT
par: C. E. Aban, et autres
Publié: (2021) -
HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
par: Peilong Li, et autres
Publié: (2021)